Market Place
Sourcing Support
All News #Library
Biotech
Lipella Goes Bankrupt, Ending Mouth Inflammation Drug Ambitions
31 Mar 2026 //
FIERCE BIOTECH
Lipella Pharma Reports Successful Phase 2a Results for LP-10
18 Sep 2025 //
GLOBENEWSWIRE
Lipella to Present Final Phase 2a Results at Zacks SCR Forum
15 Sep 2025 //
PR NEWSWIRE
Lipella CEO Issues Letter to Shareholders After Nasdaq Exit
25 Jun 2025 //
GLOBENEWSWIRE
Lipella Pharmaceuticals Announces U.S. Patent for Diagnostic Tech
17 Jun 2025 //
GLOBENEWSWIRE
Lipella Pharmaceuticals re-signs collaboration with Cook MyoSite
04 Jun 2025 //
GLOBENEWSWIRE
Lipella Pharmaceuticals to Present LP-310 Data at 2025 Meeting
15 May 2025 //
GLOBENEWSWIRE
Lipella Pharmaceuticals Abstract on Oral Lichen Planus Treatment
23 Apr 2025 //
GLOBENEWSWIRE
Lipella Pharmaceuticals Finishes Phase 2a Trial of LP-310
08 Apr 2025 //
GLOBENEWSWIRE
Lipella’s LP-310 Shows Positive Ph2a Results In Oral Lichen Planus
11 Feb 2025 //
GLOBENEWSWIRE
Lipella Pharma Granted FDA Approval for LP-310 in Oral Lichen Planus
06 Feb 2025 //
GLOBENEWSWIRE
Lipella Pharma Publishes Non-Steroid Oral Lichen Planus Treatment
03 Dec 2024 //
GLOBENEWSWIRE
Lipella Completes Ph 2a Trial of LP-310 for Oral Lichen Planus
21 Nov 2024 //
GLOBENEWSWIRE
Lipella Extended Exclusivity Of US Patent for Liposomal Platform
12 Nov 2024 //
GLOBENEWSWIRE
Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split
01 Nov 2024 //
GLOBENEWSWIRE
Lipella Pharma to Present at Spartan Capital Investor Conference
29 Oct 2024 //
GLOBENEWSWIRE
Lipella Announces US Patent Allowance for Liposomal Drug Delivery
15 Oct 2024 //
GLOBENEWSWIRE
Lipella Pharmaceuticals Reports Early Results for LP-310 Phase 2a
24 Sep 2024 //
GLOBENEWSWIRE
Lipella Presents Advanced Bladder Imaging Technique At ICICJ
21 Aug 2024 //
GLOBENEWSWIRE
Lipella doses first two patients in phase 2a Oral Lichen Planus clinical trial
13 Aug 2024 //
PHARMABIZ
Lipella Doses First Patients In Oral Lichen Planus Trial
12 Aug 2024 //
GLOBENEWSWIRE
Lipella Pharmaceuticals Announces $1.28M At-Market Registered Direct Offering
01 Aug 2024 //
GLOBENEWSWIRE
Lipella Pharmaceuticals Closes $1.28M Registered Direct Offering
01 Aug 2024 //
GLOBENEWSWIRE
Lipella Initiates Phase 2a Trial For LP-310 In Oral Lichen Planus
29 Jul 2024 //
GLOBENEWSWIRE
Lipella Pharma Doses First Patient in Human Study of Innovative Contrast Agent
05 Apr 2023 //
PR NEWSWIRE
Lipella rises as Phase II bladder disorder drug shows promise
12 Jan 2023 //
NASDAQ
Lipella to Present at January 2023 Biotech Showcase in San Francisco
09 Jan 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.